A human gene T-complex protein 10 like (TCP10L) was cloned in our lab. A previous study showed that it expressed specifically in the liver and testis. A transcription experiment revealed that TCP10L was a transcription factor with transcription inhibition activity. In this study, the human MAD4 was identified to interact with TCP10L by a yeast two-hybrid screen. This finding was confirmed by immunoprecipitation and subcellular localization experiments. As MAD4 is a member of the MAD family, which antagonizes the functions of MYC and promotes cell differentiation, the biological function of the interaction between TCP10L and MAD4 may be to maintain the differentiation state in liver cells. Also, we propose that the up-regulation of Myc is caused by the down-regulation of TCP10L in human hepatocarcinomas.
Introduction
Liver cancer is a common disease that preferentially occurs in Africa and Asia. Based on 1990 data, liver cancer is ranked sixth in a list of the estimated number of cancer cases in the world (Pisani et al., 1997) . Because of its poor prognosis and treatment, liver cancer claims an even higher proportion of all cancer deaths and was ranked in 1985 as the fourth most common cause of cancer mortality worldwide (Pisani et al., 1993) . The progress of the prognosis and treatment on liver cancer is largely dependent on the basic research on the gene regulation in the liver undergoing tumorigenesis. Transcription factors, especially those specifically expressed in the liver, may play a key role in hepatocarcinogenesis.
The Myc/Max/Mad transcription factor network is profoundly involved in the regulation of cell proliferation and differentiation (Baudino and Cleveland, 2001) . Each member of the network contains a conserved basic Helix-Loop-Helix leucine zipper motif (bHLHZip) that facilitates protein-protein heterodimerization and protein-DNA binding. MYC and MAD proteins are functionally antagonized through competitively heterodimerizing with MAX and binding to DNA at the same consensus sequence CACGTG (E box). MYC:MAX complexes can activate transcription when bound to DNA at the E-box and promote cell proliferation and transformation (Henriksson and Luscher, 1996; Facchini and Penn, 1998; Dang, 1999) . In contrast to MYC, the MAD family proteins (MAD1, MXIl, MAD3, and MAD4) inhibit cell proliferation and transformation MYC functions and promote cell differentiation (Ayer et al., 1993; Hurlin et al., 1995) . In the past decade, strong associations between oncogenesis and transcription factors possessing the leucine zipper motif have been revealed (Smith et al., 1990; Amati et al., 1993; Luscher and Larsson, 1999) .
A novel human gene T-complex 10 like (TCP10L) that is down-regulated in liver hepatoma tissues was cloned in our lab. Its homologs in mice belong to the TCP10 family. One member of this family, TCP10b t , was once considered a candidate of the T-complex responder for transmission ratio distortion (Schimenti et al., 1988; Cebra-Thomas et al., 1991) . TCP10b t is exclusively expressed in testicular germ cells (Ewulonu et al., 1993) ; however, the expression pattern of TCP10L is different from that of TCP10b t . Northern hybridization revealed that TCP10L expressed specifically in the human liver and testis among 30 tissues that were examined. A subsequent analysis, based on the dual luciferase assay system, showed that the recombinant TCP10L was a transcription factor with transcriptional inhibition activity (Chen et al., 2003, in press ). However, there is no reported function on any member of the TCP10 family in mice. The specific expression pattern and transcriptional inhibition activity indicate that TCP10L might play an important role in the liver and testis, but how its function is exerted in vivo is unclear. From previous knowledge, transcription factors often interact with other regulatory members and form transcription complexes to perform their functions. Therefore, we utilized the yeast two-hybrid system to screen the proteins that may interact with TCP10L. In this way, we hope to find the clue that can elucidate the mechanism of its potential function on gene transcription.
Materials and Methods
Materials The HEK293 cell line was purchased from ATCC (Manassas, USA) and the yeast strain EGY48(p8op-lacZ) was from CLONTECH (Franklin Lakes, USA). Matchmaker LexA twohybrid system, human liver cDNA library, and vectors of pLexA, pB42AD, pCMV-HA, pCMV-Myc, and pEGFP were products of CLONTECH. The pCDNA3.1/Myc-His(-)B vector was purchased from Invitrogen (Calsbad, USA). The recombinant plasmid pGEM-T/TCP10L, which contained the coding region of TCP10L, was constructed in our lab (Chen et al., 2003 J. Human Genet., in press Yeast two-hybrid screening A yeast two-hybrid assay was performed with the Matchmaker LexA two-hybrid system, according to the instructions from CLONTECH. To construct the bait plasmids, the full-length (1 to 645 bp), the front half (head, 1 to 315 bp), and the back half (tail, 307 to 645 bp) of the coding region of TCP10L cDNA were produced by PCR with pGEM-T/TCP10L as the template. The primers for the full-length coding region (P1: 5'-CGGAATTCATGCTGGCAGGTCAACTC-3', P2: 5'-TAAACT CGAGTCAGACACCCCCCC-3'), head region (P1, P3: 5'-GACC TCGAGTTACTTCCTGGCTTTCC-3') and tail region (P4: 5'-GC CGAATTCGCCAGGAAGAAATCTGC-3',P2) were designed to contain the EcoR I and Xho I restriction sites in the 5'-end and 3'-end, respectively. The PCR products were digested with EcoR IXho I and then subcloned in frame into the same restriction sites in the DNA-binding domain of LexA in pLexA to give pLexA/ TCP10L, pLexA/TCP10L-H (Head), and pLexA/TCP10L-T (Tail) separately. The inserted cDNA in the library was cloned into the LexA transcription activation domain in the pB42AD vector. The human liver cDNA library was screened. TCP10L was used as a bait to screen the reporter genes LEU2 and lacZ. Transformed yeast was grown on plates that lacked both histidine and tryptophan. Individual cDNA of interest was purified from the positive clones and re-transformed into yeast for confirmation.
In vivo interaction assay
The interaction between TCP10L and Mad4 in vivo was performed in HEK293 cells. Recombinant plasmid pCMV-HA/TCP10L was constructed with primers (P5: 5'-ATCGAATTCACATGCTGGCAGGTC-3', P6: 5'-AATGGTACC TCAGACACCCCCC-3') and pGEM-T/TCP10L as the template. The open-reading frame of Mad4 was directly cloned from the human liver cDNA library with primers (P7: 5'-ACGGAATTCCA ATGGAGCTGAACTCC-3', P8: 5'-AATGGTACCCTACGAGAG GGCGGG-3'), then ligated into the pCMV-Myc vector to give pCMV-Myc/Mad4. HEK293 cells were cultured in a DMEM medium that was supplemented with 10% bovine serum. The 2 × 10 5 HEK293 cells were seeded on the 35 mm disk and maintained at 37 o C in a CO 2 incubator until grown to 80% confluency prior transfection. Transient transfection was performed by the Lipofectin method as the protocol from Invitrogen. The cells were harvested 48 h after transfection.
Transfected cells were washed 4 times with an ice-cold phosphate-buffered saline (PBS) then lysed on ice for 30 min in a PBS lysis buffer [5 mM EDTA, 0.5% NP-40, 0.1 mM PMSF plus 10 µM pepstatin A, 10 µM leupeptin and 25 µg/ml aprotinin, purchased from Roche Co., Shanghai, P. R. China] with gentle rocking. The cells were then centrifuged at 12,000 × g for 10 min at 4 o C to remove the insoluble material. The supernant was collected after preclearing the lysate by protein G/protein A agarose beads for 2 h at 4 o C with rotation. At the same time, the mouse anti-HA monoclonal antibody (HA mAb) or mouse anti-Myc monoclonal antibody (Myc mAb) was incubated with protein G/protein A agarose beads for 2 h at 4 o C, then washed 3 times with PBS and resuspended in PBS. The precleared lysate and antibody-agarose beads were mixed and incubated for 2.5 h at 4 o C with gentle rocking. The immune complex was collected by centrifugation and washed 4 times with the cell lysis buffer, then solubilized in a 1 × SDS buffer. The immune complex and lysate (control) were separated by 12% SDS-PAGE and electroblotted to a nitrocellulose membrane. Western blotting was performed using Myc mAb or HA mAb and a corresponding secondary antibody. The immunoreactive proteins were visualized using the enhanced chemiluminescence detection system that was purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, USA).
Fluorescence and confocal microscopy TCP10L and MAD4 proteins were localized by immunofluorescence and confocal microscopy. The TCP10L gene was constructed to pcDNA3.1/mycHis(-)B vector with primers (P9: 5'-GTAGAATTCATGCTGGCA GGTCAAC-3', P10: 5'-GTCAAGCTTAGGACACCCCCCC-3') to form a fusion protein with a Myc tag (TCP10L-Myc). Mad4 was constructed to the pEGFP vector with primers (P11: 5'-ACTAG ATCTATGGAGCTGAACTCCCTGC-3', P12: 5'-ATAGGATCCT TCGAGAGGGCGGGGC-3') to form the EGFP-MAD4 fusion protein.
The HEK293 cells were grown on coverslips and co-transfected, as described in "Materials and Methods". After a 48 h-transfection, the cells were fixed in 4% paraformaldehyde for 10 min. The coverslips were washed once with TBS (50 mM Tris-HCl pH7.4, 150 mM NaCl), then the cells were permeabilized with 0.2% Triton X-100 for 5 min. The slips were washed 3 times for 5 min each with TBS, and the cells quenched in fresh 0.1% sodium borohydride in TBS for 5 min. All of the slips were blocked with a blocking buffer (1% horse serum, 1% BSA, 0.02% NaN 3 , 1 × PBS) for 1 h, then washed for 5 min with TBS. Myc mAb was diluted with 1 : 200 (v/v) in TBS (containing 1% BSA) and centrifuged for 20 min at 12,000 × g. Stain the cells with diluted Myc mAb and incubated overnight at 4 o C. The slips were washed 3 × 5 min with TBS and incubated with Cy5 that was diluted 1 : 10000 (v/v) in TBS (containing 1% BSA) for 45 min in the dark. The slips were washed 3 × 5 min with TBS in low lighting and the coverslips were mounted on slides for the microscopy.
Results
Identification of MAD4 as TCP10L-associate protein To identify the proteins that can interact with TCP10L, the yeast two-hybrid screening technique was used. Because the TCP10L gene expressed specifically in the liver and testis tissues (for females, specifically in the liver), we screened the human liver cDNA Library.
We plated a pool of cells that contained 5 × 10 7 primary library transformants at a multiplicity of 4 onto the selection induction medium. Approximately 20 positive clones were obtained, among them, 5 clones could activate both the LEU2 and LacZ reporter gene only when they contained pLexA/ TCP10L. The cDNA of interest was isolated and sequenced. A sequence homology search identified the encoded proteins. All of these peptides were in-frame to the MAX dimerization protein 4 (MAD4) and contained a partial N-terminal deletion portion of MAD4. Mad4 is a known transcriptional factor gene (GenBank accession number: NM_006454). It is transcribed into a cDNA of 3773 bp and contains an openreading frame of 630 bp that codes a peptide of 209 AA with a molecular mass of 21 KDa. The homologous proteins of MAD4 in mice belong to MAD protein family. Each member contains bHLHZip and interacts with the MAX protein through the leucine zipper domain (Ayer et al., 1993; Zervos et al., 1993; Hurlin et al., 1995; Nair and Burley 2003) . The TCP10L protein contains a leucine zipper domain in its head region (75 to 96 AA), which gives rise to the hypothesis that the interaction between MAD4 and TCP10L is mediated through the leucine zipper domain. The following experiment gave us preliminary proof. The pB42AD/Mad4 was cotransformed separately with pLexA/TCP10L-H and pLexA/ TCP10L-T. The transformants were selected on an induction medium. Only the clones that were co-transformed with pB42AD/Mad4 and pLexA/TCP10L-H turned blue, indicating the interaction of these two proteins (Fig. 1) . Because only the TCP10L head has the leucine zipper domain, leucine zipper domains mediate the interaction between MAD4 and TCP10L.
TCP10L co-precipitated with MAD4
To eliminate the false positive result from the yeast two-hybrid assay, the interaction between MAD4 and TCP10L was confirmed by an in vivo binding assay. The pCMV-HA/TCP10L and pCMVMyc/Mad4 were co-transfected into HEK293 cells. Whole cell lysates were immunoprecipitated with HA mAb or Myc mAb, followed by an immunoblot analysis using Myc mAb or HA mAb. MAD4-Myc was clearly detected in the anti-HA immunoprecipitations from the cells that were co-transfected with pCMV-HA/TCP10L and pCMV-Myc/Mad4, and for the two negative controls, pCMV-HA/TCP10L with pCMV-Myc, pCMV-HA with pCMV-Myc/Mad4, MAD4-Myc was undetectable. In addition, the MAD4-Myc that was detected in the immunoprecipitations was the same size as that in the lysate ( Fig. 2A) . TCP10L-HA was detected in anti-Myc immunoprecipitations from cells that were co-transfected with pCMV-HA/TCP10L and pCMV-Myc/Mad4, and undetectable in the two negative controls (Fig. 2B) . Therefore, the result further provided evidence that there is a direct interaction between MAD4 and TCP10L in vivo. (Fig. 2) , but their subcellular distribution patterns are unknown. Confocal microscope and immunofluorescence methods were used to localize their subcellular residence.
Subcellular co-localization of MAD4 and TCP10L MAD4 and TCP10L can directly interact in vivo
The HEK293 cells that were co-transfected with pcDNAMyc/TCP10L and pEGFP/Mad4 were harvested and processed as described in "Materials and Methods". Recombinant protein TCP10L-Myc was labeled with Cy5 waves red excitation light, while protein MAD4-EGFP produced green excitation light in the confocal microscope. MAD4 and TCP10L distributed exclusively in the nuclei of the co-transfected cells in a diffusion pattern, and were undetectable in other organelles (Fig. 3) . In the merged photo, yellow spots (overlaps between green and red) were clearly Fig. 1 . Protein-protein interaction between TCP10L (head and tail) and MAD4 demonstrated in a yeast two-hybrid analysis. The yeast strain EGY48(p8op-lacZ) was co-transformed with pLexA/TCP10L-H and pB42AD/Mad4 or pLexA/TCP10L-T and pB42AD/Mad4 to test their interaction. Then pLexA and pB42AD/Mad4, pLexA/TCP10L-T, and pB42AD were separately co-transformed to serve as the controls. All of the transformants were selected on the induction medium.
seen, which strongly indicates that MAD4 and TCP10L are co-localized in the nuclei of transfected cells.
Discussion
Using the yeast two-hybrid method and with TCP10L as a bait, the partner protein MAD4 was obtained. Also, we provided further evidence that the interaction between TCP10L and MAD4 is through leucine zipper motifs.
Subsequent research by immunoprecipitation and subcellular localization also confirmed this interaction. A Northern blot revealed that TCP10L is expressed in the human liver and testis (Chen et al., 2003, in press ). The TCP10L expression patterns are different from those of its homologue TCP10b t in mice, which is exclusively expressed in the testis. Since TCP10L can interact and co-localize with MAD4, the expression TCP10L patterns may, in some way, indicate the MAD4 expression in the liver and testis. But at present, there are no reports on the expression patterns of Mad4 in the human adult liver and testis. In cultured 3T3-L1cells, Mad4 is expressed in quiescent cells, which decreased upon serumstimulation and is reinduced as cells approach confluency (Pulverer et al., 2000) . In mouse erythroleukemia cells, Mad4 mRNA is highly induced and persists in terminally differentiated cells (Kime and Wright, 2003) , which is similar to the deduced expression pattern of Mad4 in human liver cells, since most cells in a normal liver are differentiated. During murine embryogenesis, Mad4 mRNA is primarily expressed in growth-arrested differentiating cells in the developing central nervous system and epidermis (Hurlin et al., 1995) , but continuously expressed during the proliferative and differentiative phases in the developing prostrate gland (Luo et al., 2001) ; both show the Mad4 function on cell differentiation. Based on the previous expression analysis, we suggest that the biological functions of the interaction between TCP10L and MAD4 are to maintain the differentiation state of liver cells.
During our research on the TCP10L expression pattern in human hepatoma tissues and their adjacent normal tissues, we found that TCP10L mRNA was down-regulated in 42% of the human hepatocellular carcinoma (HCC) cases by Northern blotting. Further examinations in 48 human HCC cases through RT-PCR confirmed this observation (personal communication) . But, what is the reason for the downregulation of TCP10L in human hepatoma tissues? Protooncogene c-Myc is involved in hepatocarcinogenesis (Yaswen et al., 1985; Giri and Das, 1999) , and the enhanced expression has been detected in most human HCC (Zhang et al., 1990; Gan et al., 1993) . Systematic detection of c-Myc amplification in 400 patients with HCC revealed that the amplification ratio varied in patients. The amplification was low in the single nodular HCC (12%) when compared to the multinodular HCC (38%). In metastatic HCC, the amplification was 29% in the primary tumor and 45% in the metastatic tumor. Amplification was highest in recurrent HCC, with a ratio of 38% in the primary tumor and 60% in the recurrent tumor (Wang et al., 2002) . The up-regulation of c-Myc was accompanied with the down-regulation of Mad4, because cMyc is one member of the transcription complex that represses the Mad4 expression (Kime and Wright, 2003) . Since TCP10L interacts with MAD4, its expression may, in some way, be affected by c-Myc. Therefore, the up-regulation of c-Myc may be connected to the down-regulation of TCP10L in human HCC.
We analyzed the biological functions of the TCP10L: MAD4 complex in liver, but how are their functions exerted? TCP10L interacts with MAD4, which will block the heterodimerization between MAD4 and MAX as their interaction is also mediated by leucine zippers. But it is unknown whether the TCP10L:MAD4 complex can bind to the E-box in the same way that the MAX:MAD4 complex does. If it does, then this means that TCP10L can take the role of MAX and participate in the regulation of E-box genes in the liver and testis. If not, then TCP10L may block the suppressive effect of MAD4 on MYC functions. The presence of the TCP10L:MAD4 complex in liver cells supports the idea that the complex, with the help of other members, can bind to the E-box and regulate the corresponding genes in the liver. The Max-like protein-X (MLX) is a bHLHZip protein in mice that can take the role of MAX and selectively interact with MAD1 and MAD4 (Billin et al., 1999) . TCP10L may act in a similar way. However, further study is needed to elucidate the detailed functional mechanism of the TCP10L:MAD4 complex in the liver and testis.
